Press Releases


April 27, 2026

QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone – Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths

QScreen AI Inc. has completed development of its patent-protected QAI physiological AI clinical platform, capable of identifying probable drug classes—including alcohol, opioids, benzodiazepines, stimulants, and cannabis—using only a standard laptop camera in real time. The…

Read full release →